View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
August 10, 2009

Labcyte Expands Into Chinese Market

Tekon to provide CROs with technology from Labcyte for compound management, high-throughput, and secondary screening

By CBR Staff Writer

Labcyte has selected Tekon Biotech as its distributor in China, including Hong Kong and Taiwan.

Stephen Bates, SVP of sales, marketing and service of Labcyte, said: “As we expand in Asia, Tekon will help us broaden our existing user base in the pharmaceutical industry and the contract research organizations (CROs) that service them. Tekon will provide them with technology from Labcyte for compound management, high-throughput and secondary screening.

Our established customers in China will find that Tekon will give them an opportunity for more immediate support and interaction. Tekon will also introduce us to new users in the growing genomics market. We feel that with the Labcyte platforms, Tekon can meet the genomics customers’ needs for miniaturization, precision and accuracy while remaining contamination-free,” he added.

David Hadfield, CEO of Tekon Biotech, said: “We are very excited to be chosen by Labcyte as their partner in China, it is a tremendous validation of our efforts to provide the best possible support to our customers. We see a great potential market for low-volume transfer devices in China. We believe that the growing genomics markets, especially for gene expression, SNP analysis and RNAi, will find that the need for miniaturization is met particularly well by the Labcyte technologies. It is our goal to represent only the industry leading products in every category. Labcyte offers unique, touchless liquid handling systems. Our customers will have optimal interactions with a local group while reaping the benefits of the best available technology.”

Content from our partners
Rethinking cloud: challenging assumptions, learning lessons
DTX Manchester welcomes leading tech talent from across the region and beyond
The hidden complexities of deploying AI in your business

Nick Samaras, managing director of Labcyte, said: “As the market moves to higher-density assays, the touchless liquid handling capabilities offered by the Labcyte acoustic products becomes essential. In particular, our Echo liquid handler provides superior results, reduces costs by eliminating consumables and reduces toxic wastes. Our platform technology is also being applied in other fields such as array formation, the microencapsulation of compounds, particle production, proteomics research, the transfer of ultra-viscous materials, cell-based biology and imaging mass spectrometry.”

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
THANK YOU